Skip to content
healthcare.dev

IRINOTECAN HYDROCHLORIDE

NDC 55150-353, IRINOTECAN HYDROCHLORIDE, injection, solution, from Eugia US LLC.

Product NDC
55150-353
Status
Listed
Labeler
Eugia US LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213278
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55150-353 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IRINOTECAN HYDROCHLORIDE20 mg/mL

Pharmacologic classes

Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
55150-353-01551500353011 VIAL, SINGLE-DOSE in 1 CARTON (55150-353-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7a30d551-9ea7-47ea-9073-f541bff457a3
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55150-353

Use it

Look up 55150-353 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55150-353 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55150-353. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.